COPD diagnosed prevalent cases across 7MM to reach 38.02 million in 2033, forecasts GlobalData
COPD diagnosed prevalent cases in 7MM set to increase, with significant age and regional variations, according to GlobalData
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COPD
EMA approval of Sanofi/Regeneron’s Dupixent fills biologic gap in COPD: GlobalData
Dupixent shows promise for COPD, new treatment option reduces flare - ups and improves breathing
AstraZeneca receives CDSCO approval to market its inhalation aerosol
The pressurised metered dose inhaler is recommended for the treatment and maintenance of patients with Chronic Obstructive…
Lupin partners with Cost Plus Drugs, COPD Foundation
The collaboration seeks to expand availability of Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, to COPD patients in the US…
Lupin receives approval from TGA Australia for Tiotropium dry powder
The product will be manufactured at Lupin’s Pithampur facility in India
Lupin signs MoU with Maha Govt to combat cardiovascular diseases and COPD
Collaboration to enhance healthcare services, ensure timely diagnosis, and improve accessibility of healthcare services
Zydus gets USFDA approval for Roflumilast Tablets, 250 mcg
Roflumilast reduces inflammation in the lungs that leads to chronic obstructive pulmonary disease (COPD)
Cipla launches Spirofy, strengthens its lung leadership position by facilitating early diagnosis for…
Spirofy is India's first pneumotach-based portable wireless Spirometer for diagnosis of Chronic Obstructive Pulmonary Disorder…
Lupin gets UK marketing authorisation for Luforbec 100/6 µg pMDI
Luforbec 100/6 µg pMDI is indicated for regular treatment of asthma and for the symptomatic treatment of patients with severe COPD
Lupin launches generic version of Brovana in US
It is indicated for the long-term, twice-daily maintenance treatment of bronchoconstriction in patients with COPD